Evidence map›Paper›PMID 28671713›Full record

ArticleScandinavian journal of immunology2017

Complement C5a-Induced Changes in Neutrophil Morphology During Inflammation.

S Denk, R P Taylor, R Wiegner, E M Cook, M A Lindorfer, K Pfeiffer, S Paschke, T Eiseler, M Weiss, E Barth and 7 more

Open access · bronzeAbstract read
In one paragraph

Article in Scandinavian journal of immunology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 58 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
58citing papers in PubMed, 1 pooled it
2.3field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

58 citing papers in PubMed, 1 synthesis or guideline pooled it, 87 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Review
  5. Article
  6. Review
  7. Article
  8. Review
  9. Review
  10. Article
  11. Physiologic impact of inflammation in the polytrauma patient.OTA international : the open access journal of orthopaedic trauma · 2025
    Article
  12. Review
  13. Article
  14. Immunomodulatory and cardio-protective effects of differentially originated multipotent mesenchymal stroma cells during polymicrobial sepsis in mice.European journal of trauma and emergency surgery : official publication of the European Trauma Society · 2025
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Neutrophils actively swell to potentiate rapid migration.bioRxiv : the preprint server for biology · 2024
    Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 4 institutions in 2 countries.

S DenkInstitute of Clinical and Experimental Trauma-Immunology, University Hospital Ulm, Ulm, Germany.
R P TaylorDepartment of Biochemistry and Molecular Genetics, University of Virginia School of Medicine, Charlottesville, VA, USA.
R WiegnerInstitute of Clinical and Experimental Trauma-Immunology, University Hospital Ulm, Ulm, Germany.
E M CookDepartment of Biochemistry and Molecular Genetics, University of Virginia School of Medicine, Charlottesville, VA, USA.
M A LindorferDepartment of Biochemistry and Molecular Genetics, University of Virginia School of Medicine, Charlottesville, VA, USA.
K PfeifferDepartment of General and Visceral Surgery, Ulm University, Ulm, Germany.
S PaschkeDepartment of General and Visceral Surgery, Ulm University, Ulm, Germany.
T EiselerDepartment of Internal Medicine I, Ulm University, Ulm, Germany.
M WeissDepartment of Anesthesiology, University Hospital Ulm, Ulm, Germany.
E BarthDepartment of Anesthesiology, University Hospital Ulm, Ulm, Germany.
J D LambrisDepartment of Pathology, University of Pennsylvania, Philadelphia, PA, USA.
M KalbitzDepartment of Traumatology, Hand-, Plastic-, and Reconstructive Surgery, University Hospital Ulm, Ulm, Germany.
T MartinInstitute of Pharmacology and Toxicology, University Hospital Ulm, Ulm, Germany.
H BarthInstitute of Pharmacology and Toxicology, University Hospital Ulm, Ulm, Germany.
D A C MessererInstitute of Clinical and Experimental Trauma-Immunology, University Hospital Ulm, Ulm, Germany.
F GebhardDepartment of Traumatology, Hand-, Plastic-, and Reconstructive Surgery, University Hospital Ulm, Ulm, Germany.
M S Huber-LangInstitute of Clinical and Experimental Trauma-Immunology, University Hospital Ulm, Ulm, Germany.ORCID http://orcid.org/0000-0003-2359-6516
University Hospital Ulm · DEUniversität Ulm · DEUniversity of Virginia · USUniversity of Pennsylvania · US

Funding

Role of complement in kidney disorders: from hemodialysis to transportationP01AI068730 · NIAID · UNIVERSITY OF PENNSYLVANIA · PI LAMBRIS, JOHN D · 2007 to 2018
$16.0M
NIAID NIH HHS P01 AI068730
6 · The paper itself

Abstract

The complement and neutrophil defence systems, as major components of innate immunity, are activated during inflammation and infection. For neutrophil migration to the inflamed region, we hypothesized that the complement activation product C5a induces significant changes in cellular morphology before chemotaxis. Exposure of human neutrophils to C5a dose- and time-dependently resulted in a rapid C5a receptor-1 (C5aR1)-dependent shape change, indicated by enhanced flow cytometric forward-scatter area values. Similar changes were observed after incubation with zymosan-activated serum and in blood neutrophils during murine sepsis, but not in mice lacking the C5aR1. In human neutrophils, Amnis high-resolution digital imaging revealed a C5a-induced decrease in circularity and increase in the cellular length/width ratio. Biomechanically, microfluidic optical stretching experiments indicated significantly increased neutrophil deformability early after C5a stimulation. The C5a-induced shape changes were inhibited by pharmacological blockade of either the Cl-/HCO3--exchanger or the Cl

Indexed as

Actin CytoskeletonActinsAdenosine TriphosphateCells, CulturedCell ShapeChemotaxisChloride-Bicarbonate AntiportersComplement C5aHumansInflammationNeutrophil ActivationNeutrophilsReceptor, Anaphylatoxin C5aReceptors, Purinergic P2XSignal TransductionActinsAdenosine TriphosphateC5AR1 protein, humanChloride-Bicarbonate AntiportersComplement C5aReceptor, Anaphylatoxin C5aReceptors, Purinergic P2X

Identifiers

PMID28671713
PMCPMC5773343
OpenAlexW2730693644

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.